Clinical Trial Update: An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis [Phase 2, Phase 3]

View source ↗

Summary

An open-label randomized trial evaluated a new treatment regimen for patients with multi-drug resistant tuberculosis, including phase 2 and phase 3 portions; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis
• Tuberculosis

Snippet

Sponsor: University of Cape Town | Conditions: Tuberculosis, Multidrug Resistant Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED